compare tirzepatide and semaglutide vs for Weight Loss Treatment Tirzepatide Achieved Superior A1C and

Current Coverage Statistics: Approximately 31% of Canadian employers now provide coverage for GLP-1 medications for both diabetes and weight loss applications However, 56% of employers still limit coverage to diabetes-only use Fewer than 20% of private drug plans cover anti-obesity medications at all What to Expect with Private Coverage: If your private insurance includes semaglutide, most plans cover 50-80% of the medication cost, with co-payments typically ranging from $106 to several hundred dollars monthly

We generally do not recommend this practice

However, here at Regain Functional Medicine + Aesthetics, we have developed a maintenance program so our patients can enjoy the benefits of their hard work and weight loss long-term

None of the above-mentioned companies had any role in the preparation of this paper, which has been written independently and without any financial or professional help

An analysis of more than 1.3 million people found GLP-1 users had significantly lower rates of opioid overdose and alcohol intoxication